ARCHIVES

Taxotere Encouraging, CPT-11, Other Agents Entering Trials; Chabner

This article is from The Cancer Letter archive.

Vol. 18 No. 28 | July 10, 1992

Download PDF Visit The Full Archive

Related Articles

Advisors Discuss NCI Intramural Program In Closed Session, Defend Process

December 16, 1994

Nucynta ER Approved For Managing Chronic Pain In Adults

September 30, 2011

Continuing Resolution Expires March 27; NIH, NCI Hope For Budget Compromise

March 15, 2013

Two Phase II Trials Display Ramucirumab Potential Efficacy

October 26, 2012

Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women

November 26, 2010

FDA News:: ODAC Commends Ciba For Design Of Trials Legal Issues:

January 10, 1997